Published on 16 Nov 2022 on GuruFocus.com via Yahoo Finance
Is Abcam the Perfect Nasdaq Stock?
Abcam PLC (NASDAQ:ABCM) is a $3.8 billion market cap biotechnology stock on the Nasdaq Global Select Market. It is moving its primary listing from Londons AIM (previously known as the Alternative Investment Market) and will cancel its AIM shares on 13 December 2022 following shareholder approval given last week.
As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays and other research tools to address important targets in critical biological pathways.
Warning! GuruFocus has detected 4 Warning Signs with ABCM. Click here to check it out. ABCM 15-Year Financial DataThe intrinsic value of ABCMPeter Lynch Chart of ABCM